Zentalis Pharmaceuticals, Inc. - stock earnings
ZNTL Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 BeforeMarket | - / -0.7819000000 | - | - / 13.4 million | - |
ZNTL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -60.9 million USD | ? USD |
| 2023Q3 | -55.5 million USD | ? USD |
| 2023Q2 | -112.5 million USD | ? USD |
| 2023Q1 | -61.0 million USD | ? USD |
| 2022Q4 | -48.2 million USD | ? USD |
| 2022Q3 | -52.1 million USD | ? USD |
| 2022Q2 | -63.1 million USD | ? USD |
| 2022Q1 | -57.5 million USD | ? USD |
| 2021Q4 | -50.1 million USD | ? USD |
| 2021Q3 | -4.2 million USD | ? USD |
| 2021Q2 | -54.6 million USD | ? USD |
| 2021Q1 | -49.9 million USD | ? USD |
| 2020Q4 | -40.3 million USD | ? USD |
| 2020Q3 | -34.6 million USD | ? USD |
| 2020Q2 | -26.9 million USD | ? USD |
| 2020Q1 | -16.1 million USD | ? USD |
| 2019Q4 | -14.5 million USD | ? USD |
| 2019Q3 | -12.3 million USD | ? USD |
| 2019Q2 | -10.5 million USD | ? USD |
| 2019Q1 | -8.3 million USD | ? USD |
ZNTL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -292.2 million USD | ? USD |
| 2022 | -220.8 million USD | ? USD |
| 2021 | -164.3 million USD | ? USD |
| 2020 | -118.5 million USD | ? USD |
| 2019 | -46.4 million USD | ? USD |
| 2018 | -21.1 million USD | 14000 USD |
ZNTL
Price: $11.71
52 week price:
Earnings Per Share: -4.47 USD
P/E Ratio: -2.52
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 349136
Market Capitalization: 831.6 million